Press Releases

Press Releases

January 9, 2017
Investment in new products, menu and globalization coupled with 60 percent revenue growth positions Quanterix for a “breakout” 2017; CEO wins Healthcare Innovation All-Star Award
June 26, 2017
Kevin Hrusovsky, Executive Chairman and CEO of Quanterix is a finalist for the Entrepreneur Of The Year® 2017 Award in the New England program. The awards program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and…
CAMBRIDGE, MA – August 25, 2008 – Quanterix Corporation, the leader in single molecule detection, announced today that it has closed the second tranche of its Series A round, bringing the total Series A financing amount to $15 million. Proceeds from the financing will be used to validate the…
CAMBRIDGE, MA – December 17, 2010 – Quanterix, a single molecule diagnostics company providing technology with unprecedented sensitivity for the life science and in vitro diagnostics markets, today announced that David Okrongly, Ph.D., President and Chief Executive Officer, will present at the 3rd…
CAMBRIDGE, MA – September 19, 2011 – Quanterix Corporation, using its revolutionary Single Molecule Array (SiMoA™) technology to enable unprecedented high value research and diagnostic products based on its ultrasensitive protein detection platform, announced today that Martin D. Madaus, Ph.D has…
LEXINGTON, MA – July 20, 2012 – Quanterix Corporation, developer of the Single Molecule Array (Simoa) technology, announced today that it has appointed Paul Chapman as its new President and Chief Executive Officer. Mr. Chapman joins the company at a pivotal time, as it moves from development to…
LEXINGTON, Mass., September 17, 2013 – delivering the world’s most sensitive single molecule immunoassay measurement for the benefit of human health, today announced its recently published Multiplexed Single Molecule Immunoassays study that successfully demonstrated the ability to measure multiple…
Lexington--(BUSINESS WIRE)– May 28, 2014 Quanterix, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, announced today it has been selected as a Red Herring Top 100 North America award winner. The Top 100 award winners are…
LEXINGTON, MA – March 5, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN), will use Quanterix…
LEXINGTON, MA – July 23, 2015 Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced it was named a final winner of GE and the NFL’s Head Health Challenge I’s phase two grant. There were…